SPP1 and diabetes mellitus: While OPN has shown promise in reflecting inflammatory and atherosclerotic activity, its utility as a standalone marker is limited by methodological heterogeneity, variations in study cohorts, and the influence of pathological confounders like systemic inflammation, diabetes, and renal dysfunction.